Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors

被引：195

作者：

Park, Anthony K. ^{[1
,2
,3
]}

Fong, Yuman ^{[3
]}

Kim, Sang-In ^{[3
]}

Yang, Jason ^{[1
]}

Murad, John P. ^{[1
,2
]}

Lu, Jianming ^{[3
]}

Jeang, Brook ^{[1
]}

Chang, Wen-Chung ^{[1
]}

Chen, Nanhai G. ^{[3
]}

Thomas, Sandra H. ^{[4
]}

Forman, Stephen J. ^{[1
,5
]}

Priceman, Saul J. ^{[1
,5
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA 91010 USA

[2] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA

[3] City Hope Natl Med Ctr, Dept Surg, Duarte, CA 91010 USA

[4] City Hope Natl Med Ctr, Dept Clin & Translat Project Dev, Duarte, CA 91010 USA

[5] City Hope Natl Med Ctr, Dept Immunooncol, Beckman Res Inst, Duarte, CA 91010 USA

来源：

SCIENCE TRANSLATIONAL MEDICINE | 2020年 / 12卷 / 559期

基金：

美国国家卫生研究院;

关键词：

CHIMERIC ANTIGEN RECEPTOR; T-CELL THERAPY; PEXA-VEC JX-594; VACCINIA VIRUS; ADOPTIVE TRANSFER; OVARIAN-TUMORS; POXVIRUS; CD19; PHASE-1; ORTHOPOXVIRUS;

D O I：

10.1126/scitranslmed.aaz1863

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Chimeric antigen receptor (CAR)-engineered T cell therapy for solid tumors is limited by the lack of both tumor-restricted and homogeneously expressed tumor antigens. Therefore, we engineered an oncolytic virus to express a nonsignaling, truncated CD19 (CD19t) protein for tumor-selective delivery, enabling targeting by CD19-CAR T cells. Infecting tumor cells with an oncolytic vaccinia virus coding for CD19t (OV19t) produced de novo CD19 at the cell surface before virus-mediated tumor lysis. Cocultured CD19-CART cells secreted cytokines and exhibited potent cytolytic activity against infected tumors. Using several mouse tumor models, delivery of OV19t promoted tumor control after CD19-CART cell administration. OV19t induced local immunity characterized by tumor infiltration of endogenous and adoptively transferred T cells. CART cell-mediated tumor killing also induced release of virus from dying tumor cells, which propagated tumor expression of CD19t. Our study features a combination immunotherapy approach using oncolytic viruses to promote de novo CART cell targeting of solid tumors.

引用

页数：13

共 55 条

[1] Prospects for combined use of oncolytic viruses and CAR T-cells [J].

Ajina, Adam ;

Maher, John .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5

[2] Vaccinia virus hijacks EGFR signalling to enhance virus spread through rapid and directed infected cell motility [J].

Beerli, Corina ;

Yakimovich, Artur ;

Kilcher, Samuel ;

Reynoso, Glennys, V ;

Flaeschner, Gotthold ;

Mueller, Daniel J. ;

Hickman, Heather D. ;

Mercer, Jason .

NATURE MICROBIOLOGY, 2019, 4 (02) :216-225

[3]

Bommareddy PK, 2018, NAT REV IMMUNOL, V18, P498, DOI 10.1038/s41577-018-0014-6

[4]

Breitbach CJ, 2015, METHODS MOL BIOL, V1317, P341, DOI 10.1007/978-1-4939-2727-2_19

[5] Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans [J].

Breitbach, Caroline J. ;

Burke, James ;

Jonker, Derek ;

Stephenson, Joe ;

Haas, Andrew R. ;

Chow, Laura Q. M. ;

Nieva, Jorge ;

Hwang, Tae-Ho ;

Moon, Anne ;

Patt, Richard ;

Pelusio, Adina ;

Le Boeuf, Fabrice ;

Burns, Joe ;

Evgin, Laura ;

De Silva, Naomi ;

Cvancic, Sara ;

Robertson, Terri ;

Je, Ji-Eun ;

Lee, Yeon-Sook ;

Parato, Kelley ;

Diallo, Jean-Simon ;

Fenster, Aaron ;

Daneshmand, Manijeh ;

Bell, John C. ;

Kirn, David H. .

NATURE, 2011, 477 (7362) :99-U102

[6] Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].

Brentjens, Renier J. ;

Riviere, Isabelle ;

Park, Jae H. ;

Davila, Marco L. ;

Wang, Xiuyan ;

Stefanski, Jolanta ;

Taylor, Clare ;

Yeh, Raymond ;

Bartido, Shirley ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Bernal, Yvette ;

Pegram, Hollie ;

Przybylowski, Mark ;

Hollyman, Daniel ;

Usachenko, Yelena ;

Pirraglia, Domenick ;

Hosey, James ;

Santos, Elmer ;

Halton, Elizabeth ;

Maslak, Peter ;

Scheinberg, David ;

Jurcic, Joseph ;

Heaney, Mark ;

Heller, Glenn ;

Frattini, Mark ;

Sadelain, Michel .

BLOOD, 2011, 118 (18) :4817-4828

[7] A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models [J].

Chaurasiya, Shyambabu ;

Chen, Nanhai G. ;

Lu, Jianming ;

Martin, Nikolas ;

Shen, Yinan ;

Kim, Sang-In ;

Warner, Susanne G. ;

Woo, Yanghee ;

Fong, Yuman .

CANCER GENE THERAPY, 2020, 27 (3-4) :125-135

[8] Successful Eradication of Established Peritoneal Ovarian Tumors in SCID-Beige Mice following Adoptive Transfer of T Cells Genetically Targeted to the MUC16 Antigen [J].

Chekmasova, Alena A. ;

Rao, Thapi D. ;

Nikhamin, Yan ;

Park, Kay J. ;

Levine, Douglas A. ;

Spriggs, David R. ;

Brentjens, Renier J. .

CLINICAL CANCER RESEARCH, 2010, 16 (14) :3594-3606

[9] Evaluation of cytokine toxicity induced by vaccinia virus-mediated IL-2 and IL-12 antitumour immunotherapy [J].

Chen, B ;

Timiryasova, TM ;

Gridley, DS ;

Andres, ML ;

Dutta-Roy, R ;

Fodor, I .

CYTOKINE, 2001, 15 (06) :305-314

[10]

Chen H, 2013, MOL THER, V21, P167, DOI [10.1038/mt.2012.225, 10.1038/mt.2013.197]

← 1 2 3 4 5 6 →